Nuevolution Sitemap Nuevolution
 
May 9, 2012
Nuevolution Announces Receipt of Milestone Payment from Boehringer Ingelheim
 
 
September 20, 2011
Nuevolution Announces Collaboration in Drug Discovery with Boehringer Ingelheim
 
 
 
 



Chemetics
® - A Quantum Leap for Small Molecule Lead Discovery

Nuevolution A/S is a company dedicated to revolutionize fragment and HTS based lead discovery by applying its proprietary Chemetics® technologies enabling unprecedented synthesis and screening power for rapid and cost-efficient identification of drug leads.

Chemetics® represents the ultimate “convergent” drug discovery technology – a unique, patent protected fusion of proven wet chemistry and molecular biology methods producing an unrivaled capacity for synthesis and screening of millions to billions of drug-like molecules in a single test tube.


Discover ChemeticsDiscover Nuevolution
Home Sitemap Nuevolution info@nuevolution.com